You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 3.9% | 4.1% |
| Div Cover | 3.8 | 3.6 |
| Op Mrgn | 13.2% | 23.2% |
| ROCE | 46.4% |
| Latest | Forecast | |
|---|---|---|
| P/E | 6.8 | 9.5 |
| PEG | 0.3 | -4.0 |
| Price / Revenue | 1.4 | 1.3 |
| Price / Book value | 0.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 25.7% | 0.9% |
| PBT | 39.5% | n/a |
| EPS | 25.0% | -1.6% |
| DPS | 5.0% | 5.8% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | 101.64 | 28.29 | 5.33p | 12.6 | 0.3 | 38% | 1.33p | 2.0% |
| 2018-12-31 | 118.21 | 22.80 | 4.54p | 14.8 | -1.0 | -15% | 1.46p | 2.2% |
| 2019-12-31 | 135.64 | 31.08 | 5.09p | 16.5 | 1.4 | 12% | 0.54p | 0.6% |
| 2020-12-31 | 129.80 | 13.02 | 5.11p | 17.1 | 43.6 | 0% | 1.61p | 1.8% |
| 2021-12-31 | 163.21 | 18.16 | 6.39p | 17.0 | 0.7 | 25% | 1.69p | 1.6% |
| Alliance Pharma tumbles amid slower market recovery Sharecast News | 23 Nov |
|---|---|
| Alliance Pharma revenue rises, profits narrow in first half Sharecast News | 20 Sep |
| Alliance Pharma appeals competition disqualification order Sharecast News | 02 Sep |
| Update on Q4 Trading | 23-Nov-22 14:43 |
|---|---|
| Management Update | 23-Nov-22 14:43 |
| Total Voting Rights | 01-Nov-22 23:59 |
| Total Voting Rights | 04-Oct-22 23:59 |
| NOTIFICATION OF MAJOR HOLDINGS | 03-Oct-22 23:59 |